Physician profile
Joseph Evans
NPI 1114118213
$731.07
in general payments reported to CMS, 2019-2025
16 companies · $23.55 in 2025
The $23.55 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $150 · 2021: $16.61 · 2022: $43.10 · 2023: $131 · 2024: $23.60 · 2025: $23.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $131.53 | 2019 | |
| Orthofix Medical, INC. | $84.36 | 2019-2020 | |
| Radius Health, INC. | $72.23 | 2020-2022 | |
| Amgen INC. | $69.38 | 2019-2022 | |
| Depuy Synthes Sales INC. | $59.38 | 2019-2021 | |
| Medline Industries LP | $53.78 | 2023 | |
| Atricure, INC. | $53.26 | 2023 | |
| Abbott Laboratories | $41.55 | 2019-2023 | Proclaim |
| Si-Bone, INC. | $31.80 | 2019 | |
| Ferring Pharmaceuticals INC. | $24.25 | 2019 | |
| Misonix INC | $24.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.60 | 2024 | Exparel, Zilretta, Iovera |
| Bioventus LLC | $23.55 | 2025 | Exogen Ultrasound Bone Healing System |
| Takeda Pharmaceuticals U.S.A., INC. | $17.18 | 2020 | |
| Smith+Nephew, INC. | $11.22 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.